<DOC>
	<DOCNO>NCT00566774</DOCNO>
	<brief_summary>The objective randomized trial evaluate effect provide full prescription drug coverage ( i.e . co-pays , co-insurance deductible ) statin , beta-blockers , angiotensin convert enzyme inhibitor angiotensin II receptor blocker patient recently discharge hospital acute myocardial infarction .</brief_summary>
	<brief_title>A Randomized Evaluation First-dollar Coverage Post-MI Secondary Preventive Therapies</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>discharge alive hospital acute MI receive health service prescription drug benefit Aetna , Inc. enrollment Health Savings Account ( HSA ) plan age â‰¥ 65 year age time hospital discharge plan sponsor opt participate study receive medical service pharmacy coverage Aetna</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>myocardial infarction</keyword>
	<keyword>secondary prevention</keyword>
	<keyword>health insurance</keyword>
	<keyword>cost-sharing</keyword>
</DOC>